Correlation between diaphragm thickness and respiratory synergist muscle activity according to severity of chronic obstructive pulmonary disease.

The article states 47 subjects, but Table 1 lists 15 patients in each severity group, so the number analysed is unclear. All participants were men aged 55 to 70 years, so the findings may not apply to women or other age groups. This was a cross-sectional correlation study, not a treatment trial, so it cannot show that diaphragm thickness causes accessory muscle overuse or that changing muscle activity improves symptoms. No healthy control group was included, and no clinical outcomes such as breathlessness, exercise tolerance, exacerbations, or quality of life were reported. The mild COPD scalene correlation is described as negative but the reported coefficient is r=0.68, and Table 2 includes coefficients that do not exactly match the text. The paper does not report blinding of assessors or how dropouts were handled.

The paper states it was supported by the Sehan University Research Fund in 2018. No other conflicts of interest are reported.

Do not conclude that diaphragm ultrasound or accessory muscle EMG can guide COPD treatment. The study only reported correlations in a small group of men and did not test whether any intervention changed breathing, symptoms, or function.